3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Abgenix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body ABX-EGF - Prostate Cancer | Phase 2 | Completed | Abgenix | 50 | 2003-04-01 | 2005-06-24 |
| A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD ABX-IL8 - Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic | Phase 2 | Completed | Abgenix | 150 | 2001-12-01 | 2005-06-24 |
| Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease ABX-CBL - Graft Vs Host Disease | Phase 2 / Phase 3 | Completed | Abgenix | 95 | 1999-10-01 | 2005-06-24 |
Bronchitis (1) · Bronchitis, Chronic (1) · Dyspnea (1) · Graft vs Host Disease (1) · Prostatic Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
ABX-Interleukin 8 (1) · Panitumumab (1)
United States (3)